News

Trio to develop bio-based diapers
Enlarge image

BusinessDenmarkGermany

Trio to develop bio-based diapers

20.08.2012 - German chemicals company BASF, US-based Cargill and Danish biotech
Novozymes join forces to develop technologies to produce acrylic acid from
renewable feed stocks.

BASF SE, the world's largest producer of acrylic acid, will join the research collaboration with Novozymes A/S and Cargill Inc., which have already worked together on renewable acrylic technology since 2008. Both firms have been involved in the development of microorganisms that are capable of producing 3-hydroxypropionic acid (3-HP) from renewable feedstock. 3-HP is one potential chemical precursor for the synthesis of acrylic acid.

The bio-based acrylic acid will first be used to manufacture superabsorbent polymers, which can soak up large amounts of liquid and are used mainly in baby diapers and other hygiene products, but also in adhesive raw materials and coatings.

According to the three companies, the annual global market volume of acrylic acid was approximately 4.5 million tons with a value of around US-$11bn at the end of 2011, with a annual growth rate of about 4%.

http://www.european-biotechnology-news.com/news/news/2012-03/trio-to-develop-bio-based-diapers.html

GenericsEUUKHungaryGermanyItalyGreeceAustriaLuxembourgFranceSpain

26.02.2015 It is the first biosimilar monoclonal antibody in many European markets: Mundipharma and Hospira are launching Celltrion’s Remicade generic.

M&AUK

23.02.2015 British drug developer Heptares has been acquired by Japanese biopharma play Sosei for US$400m (€352m).

bioethanolGermanyUKBelgiumFrance

19.02.2015 The price of oil has been sliding for months, and the European bioethanol market is taking it hard. CropEnergies AG has now stopped production at its British unit Ensus UK.

BusinessFranceGermany

17.02.2015 After Christopher Viehbacher’s unceremonious ousting last year, Sanofi has been on the look out for a new CEO. Now, sources say Bayer’s Olivier Brandicourt is set to fill the position.

BusinessUKSwitzerland

12.02.2015 Glaxosmithkline is intent on bolstering its vaccine portfolio further and has bought all shares of Swiss development partner Glycovaxyn.

InvestmentsUKEU

10.02.2015 Interest in biotechnology is on the rise among British investors. Not just one, but two major financiers are planning investment funds in the field.

IVFUKEU

04.02.2015 In a historic move, the UK is set to become the first country to allow the creation of babies with the genetic material of three people – a mother, a father and a female mitochondrial donor.

Events

All Events

Partner-Events

Planegg/Martinsried

1st Munich Biotech Pitch

Berlin (DE)

Proteomic Forum 2015

Current issue

All issues

Product of the week

Products

Stock list

All quotes

TOP

  • WILEX3.43 EUR13.20%
  • EVOLVA1.55 CHF4.73%
  • BASILEA122.20 CHF4.44%

FLOP

  • MOLOGEN5.38 EUR-4.78%
  • BIOFRONTERA1.84 EUR-3.16%
  • MORPHOSYS74.76 EUR-3.01%

TOP

  • WILEX3.43 EUR75.0%
  • BASILEA122.20 CHF16.9%
  • FORMYCON16.70 EUR16.8%

FLOP

  • SANTHERA94.55 CHF-10.4%
  • STRATEC BIOMEDICAL43.49 EUR-7.5%
  • BIOFRONTERA1.84 EUR-5.6%

TOP

  • SANTHERA94.55 CHF2330.6%
  • WILEX3.43 EUR481.4%
  • FORMYCON16.70 EUR106.7%

FLOP

  • CYTOS0.34 CHF-88.7%
  • MOLOGEN5.38 EUR-55.7%
  • BIOFRONTERA1.84 EUR-53.3%

No liability assumed, Date: 27.02.2015